Aug 2026
Transforming routine solid tumor profiling with automated next-generation sequencing: experience from a reference general hospital.
Screening tumor types for which a first-line, integrated DNA-RNA NGS strategy provides a valuable advantage for rapid therapeutic decisions demonstrates that integrated DNA-RNA high-throughput NGS enables timely, precise molecular profiling for personalized therapy in solid tumors.
A. Destro, Federica Panebianco, Cecília Durães et al.
· Virchows Archiv · 0 citations